CELESTE FLEMING: Open Payments
NPI 1184875569 · DAPHNE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$577 in 14 payments from 9 companies in 2025. Trend: 2023 $952 · 2024 $1,003 · 2025 $577
Food & beverage: $577
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 5 | $161 |
| Paratek Pharmaceuticals, Inc. | 1 | $120 |
| Boston Scientific Corporation | 1 | $116 |
| ConvaTec Inc. | 2 | $49 |
| Ossur Americas, Inc. | 1 | $44 |
| PolyNovo North America LLC | 1 | $31 |
| Tactile Systems Technology Inc | 1 | $26 |
| Bard Peripheral Vascular, Inc. | 1 | $18 |
| BioWound Solutions, Inc. | 1 | $13 |
Products named: NUZYRA, General - Vascular Intervention, VENASEAL, ENDURANT IIS, NOVOSORB BTM, AQUACEL AG+ EXTRA, Flexitouch Plus, INNOVAMATRIX AC.
Industry payments across AL — which companies pay providers there.
